Sep 19, 2016 | Biomarkers, News
In BiomarkerBase we track biomarker use in trials, including those biomarkers used as patient selection criteria in particular clinical trials. We used this capability in a report we recently co-authored with BIO and Informa on clinical trials success rates (spoiler:...Aug 26, 2016 | Biomarkers, News
It is more costly to get biomarker information from public sources than you think. The volume of information requires technology assistance to be efficient. AI approaches like Natural Language Processing (NLP) are the best bet for efficient gathering of clinical...Jul 21, 2016 | Biomarkers, News
The team at Amplion, inventors of BiomarkerBase, is proud to share a podcast we did with The Bio Report, a member of the Levine Media Group. The Bio Report specializes in taking complex ideas at the intersection of biotechnology, business, policy, and science and...Jul 1, 2016 | Biomarkers, News
An interesting article was published today in the Journal of Precision Medicine describing the importance of testing psychiatry patients for mutations in two companion diagnostic biomarkers, CYP2D6 and CYP2C19. These are indeed important biomarkers for safe...Jun 14, 2016 | Biomarkers, News
For the chart of the week we wanted to explore the market for multi-analyte panels. We found that single biomarker tests still vastly outnumber panels. Stay tuned for more trending information in the coming weeks. My hypothesis: Panels, even outside of NGS, are...May 26, 2016 | Biomarkers, News
Biomarkers triple clinical trial success rate, says report By Melissa Fassbender, 26-May-2016 A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval....